AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021
Oct 29, 2021
30583_dirs_2021-10-28_5d69f3bf-f8c1-43b3-b20b-0b7e00f8c1f0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-04-30
Reporting Person: Ajer Jeffrey Robert (EVP, Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-30 | Common Stock | A | 342 | $62.407 | Acquired | 58592 | Direct |
| 2021-10-26 | Common Stock | S | 2739 | $73.60 | Disposed | 55853 | Direct |
Footnotes
F1: Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.
F2: Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19